Recent advancements in the cardiovascular drug carriers

Baljeet Singh; Tarun Garg; Amit K. Goyal; Goutam Rath

doi:10.3109/21691401.2014.937868

Recent advancements in the cardiovascular drug carriers

Baljeet Singh, Tarun Garg, Amit K. Goyal, Goutam Rath

Research output: Contribution to journal › Article › peer-review

46 Scopus citations

Abstract

Cardiovascular disease is the disease that affects the cardiovascular system, vascular diseases of the brain and kidney, and peripheral arterial disease. Despite of all advances in pharmacological and clinical treatment, heart failure is a leading cause of morbidness and mortality worldwide. Many new therapeutic advance strategies, including cell transplantation, gene delivery or therapy, and cytokines or other small molecules, have been research to treat heart failure. The main aim of this review article is to focus on nano carriers advancement and addressing the problems associated with old and modern therapeutics such as nonspecific effects and poor stability.

Original language	English (US)
Pages (from-to)	216-225
Number of pages	10
Journal	Artificial Cells, Nanomedicine and Biotechnology
Volume	44
Issue number	1
DOIs	https://doi.org/10.3109/21691401.2014.937868
State	Published - Jan 1 2016
Externally published	Yes

Bibliographical note

Generated from Scopus record by KAUST IRTS on 2023-10-12

ASJC Scopus subject areas

Biotechnology
Biomedical Engineering
Pharmaceutical Science
Medicine (miscellaneous)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3109/21691401.2014.937868

Cite this

@article{4b6cea595c594b6ab05bc5acb6332937,

title = "Recent advancements in the cardiovascular drug carriers",

abstract = "Cardiovascular disease is the disease that affects the cardiovascular system, vascular diseases of the brain and kidney, and peripheral arterial disease. Despite of all advances in pharmacological and clinical treatment, heart failure is a leading cause of morbidness and mortality worldwide. Many new therapeutic advance strategies, including cell transplantation, gene delivery or therapy, and cytokines or other small molecules, have been research to treat heart failure. The main aim of this review article is to focus on nano carriers advancement and addressing the problems associated with old and modern therapeutics such as nonspecific effects and poor stability.",

author = "Baljeet Singh and Tarun Garg and Goyal, {Amit K.} and Goutam Rath",

note = "Generated from Scopus record by KAUST IRTS on 2023-10-12",

year = "2016",

month = jan,

day = "1",

doi = "10.3109/21691401.2014.937868",

language = "English (US)",

volume = "44",

pages = "216--225",

journal = "Artificial Cells, Nanomedicine and Biotechnology",

issn = "2169-1401",

publisher = "Informa Healthcare",

number = "1",

}

TY - JOUR

T1 - Recent advancements in the cardiovascular drug carriers

AU - Singh, Baljeet

AU - Garg, Tarun

AU - Goyal, Amit K.

AU - Rath, Goutam

N1 - Generated from Scopus record by KAUST IRTS on 2023-10-12

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Cardiovascular disease is the disease that affects the cardiovascular system, vascular diseases of the brain and kidney, and peripheral arterial disease. Despite of all advances in pharmacological and clinical treatment, heart failure is a leading cause of morbidness and mortality worldwide. Many new therapeutic advance strategies, including cell transplantation, gene delivery or therapy, and cytokines or other small molecules, have been research to treat heart failure. The main aim of this review article is to focus on nano carriers advancement and addressing the problems associated with old and modern therapeutics such as nonspecific effects and poor stability.

AB - Cardiovascular disease is the disease that affects the cardiovascular system, vascular diseases of the brain and kidney, and peripheral arterial disease. Despite of all advances in pharmacological and clinical treatment, heart failure is a leading cause of morbidness and mortality worldwide. Many new therapeutic advance strategies, including cell transplantation, gene delivery or therapy, and cytokines or other small molecules, have been research to treat heart failure. The main aim of this review article is to focus on nano carriers advancement and addressing the problems associated with old and modern therapeutics such as nonspecific effects and poor stability.

UR - https://www.tandfonline.com/doi/full/10.3109/21691401.2014.937868

UR - http://www.scopus.com/inward/record.url?scp=84971659490&partnerID=8YFLogxK

U2 - 10.3109/21691401.2014.937868

DO - 10.3109/21691401.2014.937868

M3 - Article

SN - 2169-1401

VL - 44

SP - 216

EP - 225

JO - Artificial Cells, Nanomedicine and Biotechnology

JF - Artificial Cells, Nanomedicine and Biotechnology

IS - 1

ER -

Recent advancements in the cardiovascular drug carriers

Abstract

Bibliographical note

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this